Discovery Projects - Grant ID: DP150104609

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Engineering Cyclic Peptides For Oral Bioavailability. The 21st century has become the age of injectable peptide therapeutics. To fully realise their benefits , peptide drugs need to become smaller, cheaper and orally deliverable. Proteins often exhibit potent and selective biological actions through small peptide surfaces. These surfaces have been mimicked in cyclic peptides that are similarly potent and selective. However, cyclic peptides do not have the right properties to be oral drugs. This project aims to re-engineer their surfaces to survive potential degradation in the gut, to permeate membranes and to withstand clearance from blood. The projected outcome of this project is new information and technology for downsizing proteins to small orally bioavailable peptides for therapeutic applications.

Funded Activity Details

Start Date: 01-01-2015

End Date: 31-12-2017

Funding Scheme: Discovery Projects

Funding Amount: $503,000.00

Funder: Australian Research Council